Company news: AstraZeneca

Share this article:
AstraZeneca chief David Brennan said the company will see nearly a billion dollars shaved off its profits for 2010 and 2011 combined due to healthcare reform legislation in the US, Reuters reported. “My US profit and loss statement for 2010 will take a $300 million hit on healthcare reform and double that next year, so it is a pretty significant impact on our business,” Brennan was quoted as saying at a conference. Gains in sales to previously uninsured Americans are expected to more than make up for that loss in the long term.

When asked if they knew where to find online resources to manage their condition, eight in 10 respondents to a MedTera survey said “Not at all.” Fifty-four percent of the 7,028 respondents also said the same thing when asked if they had the information needed to manage their illness when they left their physicians' offices and when asked if they knew where to find info on side effects, while 53% knew nothing of dietary recommendations for their condition.
 
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Imbruvica lassoes CLL indication

The FDA slapped a Breakthrough Therapy label on the CLL indication pursuit in February.

FDA asks social media "how'm I doin?"

The FDA's Center for Drug Evaluation and Research's Office of Communications wants a system that will help assess its messaging reach across the interwebs and its many forums.

Reckitt Benckiser wants out of pharma

The company plans to spin off its pharmaceutical unit.